Title: Prognostic analysis of hepatocellular carcinoma based on Cuproptosis -associated
lncRNAs
Version: 4 Date: 26 Feb 2024
Reviewer's report:
1.The first appearance of abbreviations refers to using the full name first and then abbreviating
it in the main text
2.The subsequent inquiry involves specifying the name of the R package utilized in the analysis
methodology. It is recommended to incorporate the necessary R packages for each analytical
step within the method section, without necessitating a detailed enumeration.
3.The issue addresses the partitioning of the TCGA database into training and validation subsets,
with a request to include the respective sample sizes of these sets in the results section.
4.The fourth inquiry pertains to the absence of a reference to the website containing the drug
sensitivity data. Kindly provide this information.
5.Additionally, the fifth concern arises from the observation that while the author's graphical
presentation is commendable, the written content appears deficient, prompting skepticism
regarding potential third-party assistance. Should such assistance have been utilized, it is
recommended to disclose this in the acknowledgments section.
Title: Prognostic analysis of hepatocellular carcinoma based on Cuproptosis -associated
lncRNAs
Version: 4 Date: 26 Feb 2024
Reviewer's report:
1.The first appearance of abbreviations refers to using the full name first and then abbreviating
it in the main text
2.The subsequent inquiry involves specifying the name of the R package utilized in the analysis
methodology. It is recommended to incorporate the necessary R packages for each analytical
step within the method section, without necessitating a detailed enumeration.
3.The issue addresses the partitioning of the TCGA database into training and validation subsets,
with a request to include the respective sample sizes of these sets in the results section.
4.The fourth inquiry pertains to the absence of a reference to the website containing the drug
sensitivity data. Kindly provide this information.
5.Additionally, the fifth concern arises from the observation that while the author's graphical
presentation is commendable, the written content appears deficient, prompting skepticism
regarding potential third-party assistance. Should such assistance have been utilized, it is
recommended to disclose this in the acknowledgments section.
Please review this paper.
user
Title: Prognostic analysis of hepatocellular carcinoma based on Cuproptosis -associated
lncRNAs
Version: 4 Date: 26 Feb 2024
Reviewer's report:
1.The first appearance of abbreviations refers to using the full name first and then abbreviating
it in the main text
2.The subsequent inquiry involves specifying the name of the R package utilized in the analysis
methodology. It is recommended to incorporate the necessary R packages for each analytical
step within the method section, without necessitating a detailed enumeration.
3.The issue addresses the partitioning of the TCGA database into training and validation subsets,
with a request to include the respective sample sizes of these sets in the results section.
4.The fourth inquiry pertains to the absence of a reference to the website containing the drug
sensitivity data. Kindly provide this information.
5.Additionally, the fifth concern arises from the observation that while the author's graphical
presentation is commendable, the written content appears deficient, prompting skepticism
regarding potential third-party assistance. Should such assistance have been utilized, it is
recommended to disclose this in the acknowledgments section.
assistant